NOV 03, 2019 8:53 AM PST

Can CRISPR Replace Antibiotics?

WRITTEN BY: Annie Lennon

Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019). Although some have thus called for the development of new antibiotics, researchers are now finding that CRISPR technology may hold a better solution. 

Aside from leading to antibiotic resistance from excessive usage, conventional antibiotics are known to act indiscriminately. Although they eradicate pathogens, they often eradicate healthy microbiota too. The eradication of this microbiota by many antibiotics has been shown to lead to further health issues including metabolic illnesses, cancer, mental health issues and neurodegenerative diseases (Leitch: 2019).  

Unlike antibiotics however, with CRISPR, researchers are able to specifically target pathogenic bacteria and leave healthy microbes alone by engineering each CRISPR vehicle to target only one kind of pathogen. And already, preliminary tests have yielded positive results. 

In a study by the Broad Institute of MIT and Harvard, researchers were able to use CRISPR enzyme, Cas13, to detect and kill three different single-stranded RNA viruses: influenza A virus, lymphocytic choriomeningitis virus and vesicular stomatitis virus (Freije: 2019). A great proof-of-concept, given CRISPR’s efficacy in treating these relatively mild human viruses, researchers feel it is likely that the technology may be modified to treat more deadly infections too. 

Another advantage CRISPR holds over conventional antibiotics is that it can be easily tweaked when needed, meaning treatments are better able to keep up with frequent viral mutations that increasingly render antibiotics ineffective. According to Cameron Myhrvold, a postdoctoral researcher at the Broad Institute, “If a virus evolves and mutates, we can simply change the Crispr system to match whatever the virus is doing (Sheikh: 2019).”

Yet, despite promise in the technology and exciting early results, researchers have warned that we are still a long way from being able to take CRISPR pills to oust viruses. With experiments so far having been done in petri dishes or via computational models, the next step for researchers is thus to see whether CRISPR treatments show the same results in living animals and humans, and of course, whether they can be made cheaper than conventional therapies (ibid.). 


 

Sources 

 

Jacobs, Andrew: New York Times  

Leitch, Carmen: Labroots

Freije, Catherine A.: Molecular Cell

Sheikh, Knvul: New York Times

 

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
JAN 17, 2020
Genetics & Genomics
JAN 17, 2020
Soybean Oil Found to Change Gene Expression in the Brain
Soybean oil is used for frying and for making foods like margarine and salad dressing. It's the most commonly produced and consumed edible oil in the US....
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
JAN 28, 2020
Genetics & Genomics
JAN 28, 2020
Developing a Gene Therapy to Treat Duchenne Muscular Dystrophy
Because of a genetic mutation, people that have Duchenne muscular dystrophy lack functional copies of a protein called dystrophin....
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
How To Choose The Right DNA Testing Kit For You
One of the most exciting scientific advancements in the past decade, at least in terms of its impact on pop culture, was the sudden accessibility of home D...
FEB 02, 2020
Genetics & Genomics
FEB 02, 2020
Ranking the Importance of Genes to Find Rare Disease-Causing Mutations
A team of scientists has classified genes according to how necessary they are for the survival of an organism....
MAR 04, 2020
Genetics & Genomics
MAR 04, 2020
DNA Fragments and Cartilage Recovered From 75-Million-Year-Old Dinosaur Bones
An international team of researchers has analyzed cartilage from a baby duckbilled dinosaur, and they have identified bits of preserved proteins and what seems to be chromosomes....
Loading Comments...